Research In Cancer and Tumor

International Journal of Cancer and Tumor is a peer-reviewed international journal which provides a forum for prompt communication of original and innovative research findings that have relevance to understanding the etiology of cancer and to improving the treatment and survival of patients.


Karl-Anton Kreuzer

Editorial Board Member of Research In Cancer and Tumor

Professor, Department of Internal Medicine (Hematology & Oncology), University at Cologne, Germany

Research Areas

Hematology, Leukemia, Lymphoma, Hematological Diagnostics

Education

2009Chamber of Physicians, Cologne/Germany: Board certification in Hematology/Oncology
2006Habilitation at the Medical Faculty of the University at Cologne/Germany: 'Molecular diagnostics in hematology'
2004Chamber of Physicians, Berlin/Germany: Board certification in Internal Medicine
1999University of Texas, MD Anderson Cancer Center, Houston/USA: Clinical Exchange Program
1997University of Bonn Medical School, Bonn/Germany: M.D. thesis
1996University of Bonn Medical School, Bonn/Germany: M.D. exam. University of Pittsburgh, Pittsburgh Transplantation Institute (Prof. Dr. A. Thomson), Pittsburgh/USA: Research training. University of Zurich, Department of Medicine (Prof. Dr. A. Schaffner), Zu
1995The Weizmann Institute of Science, Department of Chemical Immunology (Prof. Dr. I. Pecht), Rehovot/Israel: Research training. The Wistar Institute of Anatomy and Biology, Department of Immunobiology (Prof. Dr. G. Trinchieri), Philadelphia/USA: Research tr
1994Beilinson Medical Center, Department of Clinical Immunology (Professor Dr. I. Pick), Tel Aviv/Israel: Clinical training
1990Technical University of Munich Medical School; Munich/Germany: Medical studies, St. Rita's Hospital, Department of Gynecology and Obstetrics, Changanacherry/India: Clinical training, University of Queensland, Mater Misericordiae Hospital, Department of Su
1989University of Bonn Medical School, Bonn/Germany: Pre-medical studies

Experience

20082008 University at Cologne, Department I of Internal Medicine, Cologne/Germany: Consultant
20072007 University at Cologne, Department I of Internal Medicine, Cologne/Germany: Head of the Laboratory for Molecular Hematology and Oncology
20042004 University at Cologne, Department I of Internal Medicine, Cologne/Germany: Senior Physician
19971997 Humboldt-University at Berlin, Charité Campus Virchow-Klinikum, Department of Medicine, Division of Hematalogy and Oncology, Berlin/Germany: Registrar

Membership

Advances in Hematology, Hindawi Publishing Corporation, New York/NY, USA
Hematology Reports, Pagepress Inc., Pavia, Italy
Therapeutic Advances in Hematology, SAGE Publications, Thousand Oaks/CA, USA
Open Journal of Blood Diseases, Scientific Research Publishing Inc., Irivine/CA, USA
Recent Patents on Biomarkers, Bentham Science Publishers Ltd., Oak Park/IL, USA

Publications: Journals

[1]  Filipovich A, Gehrke I, Poll-Wolbeck SJ, Kreuzer KA. Physiological inhibitors of Wnt signaling. Eur J Haematol 2011; 86: 453-465.
[2]  Hertweck MK, Erdfelder F, Kreuzer KA. CD44 in hematological neoplasias. Ann Hematol 2011; 90: 493-508.
[3]  Skoetz N, Kluge S, Monsef I, Bauer K, Siebert H, Kreuzer KA, Engert A. Twelfth biannual report of the Cochrane Haematological Malignancies Group--focus on tyrosine kinase inhibitors. J Natl Cancer Inst 2011;103: E1.
[4]  Uhrmacher S, Erdfelder F, Kreuzer KA. Flow cytometry and polymerase chain reaction-based analyses of minimal residual disease in chronic lymphocytic leukemia. Adv Hematol 2010; 1: 1-11
[5]  Gehrke I, Gandhirajan RK, Kreuzer KA. Targeting the WNT/beta-catenin/TCF/LEF1 axis in solid and haematological cancers: Multiplicity of therapeutic options. Eur J Cancer 2009; 45: 2759-2767
[6]  Borchmann P, Eichhorst B, Hellmann M, Hübel K, Kochanek M, Kreuzer KA, Reiser M, Hallek M. Hämatologie 2008. Dtsch Med Wochenschr 2008 Jun; 133: 1400-1404
[7]  Bohn A, Lass U, Kreuzer KA, Oettle H, Schmidt CA. Diagnostik der minimalen Resterkrankung bei Leukämien durch Echtzeit-Fluoreszenz-PCR. J Lab Med 2000; 24: 69-75
[8]  Kreuzer KA, Rockstroh JK. Pathogenesis and pathophysiology of anemia in HIV infection. Ann Hematol 1997; 75: 179-187

Publications: Books/Book Chapters

[1]  Kreuzer KA, Hallek M. Grundlagen der Hämatopoese (Chapter 10). In: Innere Medizin. Classen M, Diehl V, Kochsieck V, Böhm M, Hallek M, Schmiegel W. (Eds.), Elsevier, München 2007
[2]  Kreuzer KA, Hallek M. Molekulare Untersuchungsmethoden in der Hämatologie (Chapter 11). In: Innere Medizin. Classen M, Diehl V, Kochsieck V, Böhm M, Hallek M, Schmiegel W. (Eds.), Elsevier, München 2007
[3]  Kreuzer KA, Staib P, Hallek M. Blut (Chapter 9). In: Klinische Pathophysiologie. Siegenthaler W, Blum HE (Eds.), Thieme Verlag, Stuttgart 2006
[4]  Kreuzer KA, Rockstroh JK. Erythropoietin therapy in HIV infection. In: Molecular Biology and Clinical Use of Erythropoietin. Jelkmann W (Ed.), FP Graham Publishing, Mountain Home 2002
[5]  Kreuzer KA. Der Einsatz von hämatopoetischen Wachstumsfaktoren bei der HIV-Infektion. In: Opportunistische Infektionen und Tumore im Verlauf der HIV-Infektion. Rockstroh JK, Spengler U (Eds.), Unimed-Verlag, Bremen 1999
[6]  Kreuzer KA, Rockstroh JK, Jelkmann W, Spengler U, Sauerbruch T. Serum erythropoietin, TNF-αand soluble TNF-R in HIV-infected individuals. In: HIV and cytokines. Guenounou M (Ed.), Les Editions INSERM, Paris 1997